Cargando…
A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis
Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218594/ https://www.ncbi.nlm.nih.gov/pubmed/34175563 http://dx.doi.org/10.1016/j.biomaterials.2021.120986 |